Table 5.
Information exploration over time (t) in Test Phase 1 for Pain group
| Feature | t1 (%) | t2 (%) | t3 (%) | t4 (%) | t5 (%) | t6 (%) | t7 (%) | t8 (%) | t9 (%) | t10 (%) | t11 (%) | t12 (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price | 0.0 | 1.4 | 9.9 | 11.2 | 29.4 | 27.6 | 15.1 | 9.3 | 20.0 | 20.0 | 16.6 | 41.6 |
| Brand | 1.9 | 2.8 | 4.5 | 3.0 | 2.9 | 7.6 | 15.1 | 12.5 | 13.3 | 13.3 | 41.6 | 33.3 |
| Side effect | 43.5 | 41.2 | 21.6 | 27.5 | 13.2 | 12.3 | 24.2 | 18.7 | 33.3 | 13.3 | 16.6 | 16.6 |
| Daily dose | 7.0 | 11.8 | 18.0 | 17.3 | 20.5 | 20.0 | 18.1 | 28.1 | 13.3 | 33.3 | 0.0 | 0.0 |
| Doctor’s advice | 43.5 | 37.0 | 33.3 | 33.6 | 16.1 | 15.3 | 9.0 | 6.2 | 13.3 | 6.6 | 0.0 | 0.0 |
| Availability | 3.8 | 5.5 | 12.6 | 7.1 | 17.6 | 16.9 | 18.1 | 25.0 | 6.6 | 13.3 | 25.0 | 8.3 |
| Active trials | 100.0 | 91.6 | 71.1 | 62.8 | 43.5 | 41.6 | 21.1 | 20.5 | 9.6 | 9.6 | 7.6 | 7.6 |